| Synonyms: | |
| Status: | Approved (1978) |
| Entry Type: | Protein |
| Molecule Category: | Parent |
| ATC: | H01BA02 |
| UNII: | ENR1LLB0FP |
| InChI Key | NFLWUMRGJYTJIN-PNIOQBSNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C46H64N14O12S2 |
| Molecular Weight | 1069.24 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Vasopressin and oxytocin receptor
|
0-0 | - | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Enuresis | 3 | D004775 | ClinicalTrials |
| Renal Colic | 3 | D056844 | ClinicalTrials |
| Diabetes Insipidus | 3 | D003919 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Leptospirosis | 2 | D007922 | ClinicalTrials |
| Urinary Bladder, Overactive | 2 | D053201 | ClinicalTrials |
| Hypertension | 1 | D006973 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 0 | D064129 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 16679-58-6 |
| ChEBI | 4450 |
| ChEMBL | CHEMBL1429 |
| DrugBank | DB00035 |
| DrugCentral | 817 |
| FDA SRS | ENR1LLB0FP |
| Guide to Pharmacology | 2182 |
| PubChem | 5311065 |
| SureChEMBL | SCHEMBL14027607 |